T-20 and adefovir for salvage therapy -- expect no miracles.
Gilden
D
D
D000225:Adenine / Q000009:adverse effects / Q000627:therapeutic use*; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D016527:Drug Costs; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D015507:Drugs, Investigational; D000077560:Enfuvirtide; D015700:HIV Envelope Protein gp41 / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D007262:Infusions, Intravenous; D010446:Peptide Fragments / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D016879:Salvage Therapy
D019380:Anti-HIV Agents; D015507:Drugs, Investigational; D015700:HIV Envelope Protein gp41; D010446:Peptide Fragments; D000077560:Enfuvirtide; D000225:Adenine